Newsroom

Bausch & Lomb Conducts Annual Meeting of Shareholders
And Declares Quarterly Dividend
  • Three Directors Elected
  • Annual Election of Board Members Approved
  • Quarterly Dividend of $0.13 Declared

FOR RELEASE Tuesday, April 26, 2005
 ROCHESTER, N.Y. - Bausch & Lomb (NYSE:BOL) shareholders at the Company's 2005 annual meeting today voted on three items, as follows.

Item No. 1 - Election of Directors
Shareholders elected three members to the Board of Directors to serve one-year terms expiring in 2006:

  • Paul A. Friedman, M.D., president and chief executive officer of Incyte Corporation;
  • Jonathan S. Linen, vice chairman, American Express Company;
  • William H. Waltrip, retired chairman of the board of Technology Solutions Company.

Item No. 2 - Ratification of the Appointment of Independent Accountants
Shareholders ratified the appointment of PricewaterhouseCoopers LLP as independent auditors of the Company for 2005.

Item No. 3 - Approval of Directors' Proposals to Amend the Company's Certificate of Incorporation and By-Laws to Declassify the Board of Directors
Shareholders approved amendments of various provisions that will permit the annual election of each member of the Board of Directors.  Directors elected today will serve one-year terms until the annual meeting of shareholders in 2006.  The four directors elected in 2003 and the three directors elected in 2004 will continue to serve their three-year terms.  Directors elected at the 2006 and 2007 annual meetings and thereafter will be elected annually.

Also today Bausch & Lomb declared a regular quarterly dividend of $0.13 per share on the Common stock of the Company.  The dividend is payable Friday, July 1, 2005, to shareholders of record at the close of the business day on Wednesday, June 1, 2005.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world.  Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products.  The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world.  Founded in 1853, the Company is headquartered in Rochester, New York.  Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 12,400 people worldwide and its products are available in more than 100 countries.  More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com . Copyright Bausch & Lomb Incorporated.

® / TM denote trademarks of Bausch & Lomb Incorporated.